These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 5535650)
1. Quantitative EEG changes in the human menstrual cycle. Sugerman AA; DeBruin AT; Roth CW Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):526-34. PubMed ID: 5535650 [TBL] [Abstract][Full Text] [Related]
2. Premenstrual asthma: prevalence, cycle-to-cycle variability and relationship to oral contraceptive use and menstrual symptoms. Murphy VE; Gibson PG J Asthma; 2008 Oct; 45(8):696-704. PubMed ID: 18951263 [TBL] [Abstract][Full Text] [Related]
3. Analysis of seizure dispersion during menstrual cycle in women with epilepsy. Rościszewska D Monogr Neural Sci; 1980; 5():280-4. PubMed ID: 7198716 [TBL] [Abstract][Full Text] [Related]
4. [Triella: a French multicenter double blind clinical study]. Castaigne JP Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213 [TBL] [Abstract][Full Text] [Related]
5. [The effect of hormonal contraceptives on the EEG]. Dvorák K; Bocan P Cesk Neurol Neurochir; 1980 Jan; 43(1):71-7. PubMed ID: 7357664 [TBL] [Abstract][Full Text] [Related]
6. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance. Lebrun CM Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042 [TBL] [Abstract][Full Text] [Related]
8. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
9. The electroencephalographic substratum of the awakening. Ferrara M; Curcio G; Fratello F; Moroni F; Marzano C; Pellicciari MC; Gennaro LD Behav Brain Res; 2006 Feb; 167(2):237-44. PubMed ID: 16242789 [TBL] [Abstract][Full Text] [Related]
10. Changes in the electro-encephalogram related to the menstrual cycle. Leary PM; Batho K S Afr Med J; 1979 Apr; 55(17):666. PubMed ID: 572587 [TBL] [Abstract][Full Text] [Related]
11. Gas exchange and acid-base status during the normal human menstrual cycle and in subjects taking oral contraceptives [proceedings]. Milne JA; Pack AI; Coutts JR J Endocrinol; 1977 Dec; 75(3):17P-18P. PubMed ID: 591821 [No Abstract] [Full Text] [Related]
12. Neuroticism, extroversion, and premenstrual negative affect. Gray DE; Johnson FN IRCS J Med Sci; 1976 Jun; 4(6):284. PubMed ID: 12334839 [TBL] [Abstract][Full Text] [Related]
13. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms. Apter D; Borsos A; Baumgärtner W; Melis GB; Vexiau-Robert D; Colligs-Hakert A; Palmer M; Kelly S Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):37-51. PubMed ID: 12725674 [TBL] [Abstract][Full Text] [Related]
14. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781 [TBL] [Abstract][Full Text] [Related]
15. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms. Brown C; Ling F; Wan J J Reprod Med; 2002 Jan; 47(1):14-22. PubMed ID: 11838304 [TBL] [Abstract][Full Text] [Related]
16. EEG changes during spontaneous and controlled menstrual cycles and their correlation with psychological performance. Creutzfeldt OD; Arnold PM; Becker D; Langenstein S; Tirsch W; Wilhelm H; Wuttke W Electroencephalogr Clin Neurophysiol; 1976 Feb; 40(2):113-31. PubMed ID: 55353 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Yasmin in premenstrual symptoms. Taneepanichskul S; Jaisamrarn U; Phupong V Arch Gynecol Obstet; 2007 Jun; 275(6):433-8. PubMed ID: 17111156 [TBL] [Abstract][Full Text] [Related]
18. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse). Barbosa IC; Filho CI; Faggion D; Baracat EC Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291 [TBL] [Abstract][Full Text] [Related]
19. Serum prostaglandin F levels during menstrual cycle in women using oral contraceptives. Garg SK Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):431-2. PubMed ID: 6629547 [TBL] [Abstract][Full Text] [Related]